US-Neulasta

BIOLOGICAL3 trials

Sponsors

Mylan Inc., Fresenius Kabi SwissBioSim GmbH, Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.

Conditions

HealthyHealthy ParticipantsHealthy Volunteers

Phase 1

Pharmacokinetic / Pharmacodynamic Study Comparing MYL-1401H, EU-sourced Neulasta and US-licensed Neulasta

CompletedNCT02479646

Mylan Inc.Healthy Volunteers

Start: 2014-09-30End: 2015-06-30Updated: 2022-02-14

Safety and Immunogenicity of MSB11455 in Healthy Participants

CompletedNCT03251339

Fresenius Kabi SwissBioSim GmbHHealthy

Start: 2017-08-21End: 2018-09-22Updated: 2019-07-02

A Study to Investigate the Pharmacokinetics, Pharmacodynamics, and Safety of NKF-PEG, and US-Neulasta in Healthy Adult Male Volunteers

RecruitingNCT07738991

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.Healthy Participants

Start: 2026-07-03End: 2027-04-12Target: 202Updated: 2026-07-31